<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Nutr</journal-id><journal-id journal-id-type="publisher-id">BJN</journal-id><journal-title-group><journal-title>The British Journal of Nutrition</journal-title></journal-title-group><issn pub-type="ppub">0007-1145</issn><issn pub-type="epub">1475-2662</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28290272</article-id><article-id pub-id-type="pmc">5426341</article-id><article-id pub-id-type="doi">10.1017/S0007114517000393</article-id><article-id pub-id-type="pii">S0007114517000393</article-id><article-id pub-id-type="publisher-id">00039</article-id><article-categories><subj-group subj-group-type="heading"><subject>Full Papers</subject></subj-group><subj-group subj-group-type="section"><subject>Human and Clinical Nutrition</subject></subj-group></article-categories><title-group><article-title>Strawberry and cranberry polyphenols improve insulin sensitivity in
insulin-resistant, non-diabetic adults: a parallel, double-blind, controlled and
randomised clinical trial</article-title><alt-title alt-title-type="left-running">M. Paquette <italic>et al</italic>.</alt-title><alt-title alt-title-type="right-running">Polyphenols and insulin sensitivity</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Paquette</surname><given-names>Martine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Medina Larqu&#x000e9;</surname><given-names>Ana S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Weisnagel</surname><given-names>S. J.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Desjardins</surname><given-names>Yves</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Marois</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pilon</surname><given-names>Genevi&#x000e8;ve</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Dudonn&#x000e9;</surname><given-names>St&#x000e9;phanie</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Marette</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Jacques</surname><given-names>H&#x000e9;l&#x000e8;ne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Institute of Nutrition and Functional Foods</addr-line>, <institution>Laval
University</institution>, <addr-line>Quebec</addr-line>, <country>Canada, G1V
0A6</country></aff><aff id="aff2"><label>2</label><addr-line>School of Nutrition</addr-line>, <institution>Laval University</institution>,
<addr-line>Quebec</addr-line>, <country>Canada, G1V 0A6</country></aff><aff id="aff3"><label>3</label><addr-line>Diabetes Research Unit</addr-line>, <addr-line>Endocrinology and Nephrology
Axis</addr-line>, <addr-line>Research Centre</addr-line>, <institution>Laval University
Health Center of Quebec</institution>, <addr-line>Quebec</addr-line>, <country>Canada, G1V
4G2</country></aff><aff id="aff4"><label>4</label><institution>Quebec Heart and Lung Institute</institution>, <addr-line>Quebec</addr-line>,
<country>Canada, G1V 4G5</country></aff><author-notes><corresp id="cor1"><label>*</label><bold>Corresponding author:</bold> H. Jacques, fax +<fax>1 418 656 3353</fax>, email
<email>helene.jacques@fsaa.ulaval.ca</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="ppub"><day>28</day><month>2</month><year>2017</year></pub-date><volume>117</volume><issue>4</issue><fpage>519</fpage><lpage>531</lpage><history><date date-type="received"><day>03</day><month>6</month><year>2016</year></date><date date-type="rev-recd"><day>13</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Authors 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>The Authors</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted
re-use, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0007114517000393a.pdf"/><abstract abstract-type="normal"><p>Plant-derived foods rich in polyphenols are associated with several cardiometabolic
health benefits, such as reduced postprandial hyperglycaemia. However, their impact on
whole-body insulin sensitivity using the hyperinsulinaemic-euglycaemic clamp technique
remains under-studied. We aimed to determine the effects of strawberry and cranberry
polyphenols (SCP) on insulin sensitivity, glucose tolerance, insulin secretion, lipid
profile, inflammation and oxidative stress markers in free-living insulin-resistant
overweight or obese human subjects (<italic>n</italic> 41) in a parallel, double-blind,
controlled and randomised clinical trial. The experimental group consumed an SCP beverage
(333 mg SCP) daily for 6 weeks, whereas the Control group received a flavour-matched
Control beverage that contained 0 mg SCP. At the beginning and at the end of the
experimental period, insulin sensitivity was assessed by a hyperinsulinaemic-euglycaemic
clamp, and glucose tolerance and insulin secretion by a 2-h oral glucose tolerance test
(OGTT). Insulin sensitivity increased in the SCP group as compared with the Control group
(+0&#x000b7;9 (<sc>sem</sc> 0&#x000b7;5)&#x000d7;10<sup>&#x02212;3</sup>
<italic>v</italic>. &#x02212;0&#x000b7;5 (<sc>sem</sc> 0&#x000b7;5)&#x000d7;10<sup>&#x02212;3</sup> mg/kg per min per pmol,
respectively, <italic>P</italic>=0&#x000b7;03). Compared with the Control group, the SCP group had
a lower first-phase insulin secretion response as measured by C-peptide levels during the
first 30 min of the OGTT (<italic>P</italic>=0&#x000b7;002). No differences were detected between
the two groups for lipids and markers of inflammation and oxidative stress. A 6-week
dietary intervention with 333 mg of polyphenols from strawberries and cranberries improved
insulin sensitivity in overweight and obese non-diabetic, insulin-resistant human subjects
but was not effective in improving other cardiometabolic risk factors.</p></abstract><kwd-group><title>Key words</title><kwd>Polyphenols</kwd><kwd>Strawberries</kwd><kwd>Cranberries</kwd><kwd>Insulin sensitivity</kwd><kwd>Glucose metabolism</kwd><kwd>Insulin secretion</kwd><kwd>Insulin-resistant subjects</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abbreviations</title><compound-kwd><compound-kwd-part content-type="abbrev">IAUC</compound-kwd-part><compound-kwd-part content-type="expansion">incremental AUC</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">IGT</compound-kwd-part><compound-kwd-part content-type="expansion">impaired glucose tolerance</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">M/I</compound-kwd-part><compound-kwd-part content-type="expansion">insulin sensitivity index</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">OGTT</compound-kwd-part><compound-kwd-part content-type="expansion">oral glucose tolerance
test</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">SCP</compound-kwd-part><compound-kwd-part content-type="expansion">strawberry and cranberry
polyphenols</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">UHPLC</compound-kwd-part><compound-kwd-part content-type="expansion">ultra-high performance liquid chromatography
(UHPLC)</compound-kwd-part></compound-kwd></kwd-group><counts><fig-count count="5"/><table-count count="4"/><page-count count="13"/></counts></article-meta></front><body><p>According to the International Diabetes Federation<sup>(</sup>
<xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup>, up to 592 million people worldwide (one in ten adults) will suffer from type 2
diabetes by the year 2035. This alarming increase has been predicted based on several factors,
such as the high prevalence of obesity and sedentary lifestyles<sup>(</sup>
<xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup>. Indeed in obese humans, elevated levels of NEFA, pro-inflammatory cytokines and
other factors produced by adipose tissue are key determinants of insulin resistance<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>. To maintain plasma glucose at normal levels, pancreatic <italic>&#x003b2;</italic>-cells
must adjust their function to compensate for insulin resistance. This leads to an exhaustion
of <italic>&#x003b2;</italic>-cell insulin secretion and the development of impaired glucose tolerance
(IGT) and subsequent type 2 diabetes.</p><p>In recent decades, scientific evidence has shown a link between increased consumption of
fruits and vegetables, particularly berries, and reduced incidence of type 2 diabetes<sup>(</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. Recent reviews have indeed reported that berries, like strawberries and
cranberries, can lower markers of cardiometabolic risk<sup>(</sup>
<xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref11" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>)</sup> and improve markers of the metabolic syndrome in humans<sup>(</sup>
<xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>)</sup>. It is well-documented that strawberries and cranberries are rich in polyphenols
and contain a wide variety of phenolic compounds, ranging from phenolic acids (hydroxybenzoic
and hydroxycinnamic acids), flavonoids (anthocyanins, flavonols and flavan-3-ols) to
polymerised molecules (proanthocyanidins and ellagitannins)<sup>(</sup>
<xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>)</sup>. According to several <italic>in vitro</italic> and animal studies, polyphenols
may improve glucose metabolism<sup>(</sup>
<xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>)</sup> and peripheral glucose uptake in insulin-sensitive tissues by increasing GLUT4
translocation and activity and reducing oxidative stress and inflammation<sup>(</sup>
<xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>,</sup>
<xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref>
<sup>)</sup>. It has recently been demonstrated that anthocyanin-rich bilberry extract reduces
glycaemia and improves insulin sensitivity in diabetic mice<sup>(</sup>
<xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>)</sup>. Afrin <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref13" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>)</sup> reviewed six human intervention studies on the impact of strawberries on the
metabolic syndrome, and specifically on the prevention of type 2 diabetes, but none used the
gold standard clamp technique to assess insulin sensitivity.</p><p>There are several indices calculated from the oral glucose tolerance test (OGTT), such as the
Matsuda index and insulin sensitivity index (ISI), or from fasting glycaemia and/or
insulinaemia, such as the homeostasis model assessment of insulin sensitivity (HOMA-IR) and
the quantitative insulin sensitivity check index (QUICKI), that indirectly estimate insulin
sensitivity in humans. However, these indices are not as accurate as a direct measurement of
whole-body insulin sensitivity by the hyperinsulinaemic-euglycaemic clamp<sup>(</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup>. In this respect, the clamp technique is recognised as the reference method for
measuring insulin sensitivity, and according to Antuna-Puente <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>, it should be promoted in clinical human studies. So far, only two studies have
used a hyperinsulinaemic-euglycaemic clamp to assess the effect of berry polyphenols on
insulin sensitivity<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>,</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup>. According to one study in which obese non-diabetic insulin-resistant
participants received a blueberry or placebo smoothie twice a day, the mean percentage
increase in insulin sensitivity was five times greater in the experimental group compared with
that in the placebo group<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup>. In the second study, a grape polyphenol supplement protected against a decrease
in insulin sensitivity caused by a fructose-rich diet in overweight subjects<sup>(</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup>. To the best of our knowledge, there are no human studies evaluating the effects
of strawberry and cranberry polyphenols (SCP) on insulin sensitivity assessed by the
hyperinsulinaemic-euglycaemic clamp in non-diabetic insulin-resistant subjects.</p><p>The proposed study aims to test the effects of an SCP blend incorporated in a beverage on
insulin sensitivity and related parameters in free-living overweight or obese men and women
with insulin resistance. This blend has been comprehensively analysed and contains
well-defined amounts of anthocyanins, proanthocyanidins, ellagitannins, phenolic acids and
flavonols (quercetins)<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>. The primary endpoint was the difference in the change in insulin sensitivity
after 6 weeks of SCP consumption compared with a SCP-free Control beverage. Secondary
endpoints aimed to assess changes in glucose tolerance, insulin secretion, plasma lipids,
markers of oxidative stress and inflammation, as well as to characterise plasma phenolic
components as bioavailability (efficacy) outcomes. We hypothesised that the consumption of SCP
improves insulin sensitivity and lipid profile and reduces inflammatory and oxidative stress
markers in overweight/obese subjects.</p><sec sec-type="methods" id="sec1"><title>Methods</title><sec id="sec1-1" sec-type="general"><title>Study design</title><p>This 6-week clinical trial was a randomised, double-blinded, controlled, parallel study
performed at the Institute of Nutrition and Functional Foods (INAF) in Quebec City ,
Canada. The study was conducted in accordance with the Declaration of Helsinki and all
procedures involving human subjects were approved by the Research Ethical Committee of the
Quebec University Health Center. Written informed consent was obtained from all
participants after reading a detailed consent form prior to their participation in the
study. This trial was registered at clinicaltrials.gov as NCT01766570. The study was
conducted, including analyses, between spring 2012 and fall 2015.</p></sec><sec id="sec1-2" sec-type="subjects"><title>Subjects</title><p>All subjects were overweight or obese (BMI&#x02265;25 kg/m<sup>2</sup>) and insulin resistant
based on fasting plasma insulin level &#x0003e;60 pmol/l (J.-P. Despr&#x000e9;s and J. Bergeron,
unpublished results). Subjects may have also displayed impaired fasting plasma glucose
(IFG) (5&#x000b7;6&#x02013;6&#x000b7;9 mmol/l) with or without IGT (7&#x000b7;8&#x02013;11&#x000b7;0 mmol/l) following a 2-h 75 g
OGTT<sup>(</sup>
<xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>)</sup>. Exclusion criteria included smoking, chronic disease (diabetes, respiratory,
renal, gastrointestinal or hepatic disease, CVD, hypertension, cancer), metabolic or acute
disease, use of medication or supplement known to affect lipid or glucose metabolism, use
of antioxidant supplements, major surgery in the 3 months preceding the study and
significant weight change (<sc>SEM</sc> 10 %) within 6 months prior to beginning the
study.</p><p>A total of 116 subjects, recruited in the Quebec City metropolitan area by media
advertising, were first screened to examine their eligibility to participate in this
study. Of the fifty eligible subjects who began the experimental period, forty-six
participants (twenty men and twenty-six women) aged between 40 and 70 years completed the
study. However, five subjects (three in the SCP group and two in the Control group) were
excluded from analysis because they no longer met some inclusion criteria, leading to a
total of eighteen men (nine in each of the two groups) and twenty-three postmenopausal
women (eleven in the SCP group and twelve in the Control group) who were included in the
statistical analysis (online Supplementary Fig. S1).</p></sec><sec id="sec1-3" sec-type="general"><title>Experimental groups</title><p>The polyphenol blend and Control were provided as energy-free beverages formulated with
purified water and small amounts of sucralose. Red food colour was added in the Control
beverage. Both beverages thus had the same taste and visual aspect. Both were formulated
in a single batch by Atrium Innovations Inc. and were provided in dark bottles at 120
ml/d. The bottles were sealed and kept at room temperature with limited light exposure.
The polyphenol blend contained 1&#x000b7;84 g of a mixture of dry strawberry
(<italic>Fragaria&#x000d7;ananassa Duch</italic>) and cranberry (<italic>Vaccinium
macrocarpon</italic> L.) polyphenol extracts (GlucoPhenol<sup>TM</sup>; NutraCanada)
providing an average daily dose of 333 (SD 12) mg of polyphenols (18 % total polyphenols
in GlucoPhenol<sup>TM</sup>, as determined by Folin&#x02013;Ciocalteu assay). SCP
(GlucoPhenol<sup>TM</sup>) complies with good manufacturing practices according to
Health Canada regulations. To determine the amount of polyphenols to be used for the
present study, we first conducted a bioavailability study in rats with different doses of
SCP<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>. The dose of 333 mg polyphenols was chosen as corresponding, for a 60 kg
human, to the dose (36 mg/kg) that induced the highest concentration of plasma total
phenolic metabolites in the rat<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>. The total phenolic content was monitored in the SCP beverage throughout the
study, ensuring a minimum of 300 mg/d. In order to simulate the taste and colour of the
SCP-containing beverage, a pomegranate-derived red food colour was used in the SCP-free
Control beverage providing a small quantity of polyphenols. The two beverages were
characterised for their phenolic composition as previously described<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup> (<xref ref-type="table" rid="tab1">Table 1</xref>). In brief,
proanthocyanidins were analysed by normal-phase HPLC with fluorescence detection, and
quantified using an epicatechin standard. Phenolic acids were analysed using reverse-phase
ultra-high performance liquid chromatography (UHPLC) coupled with tandem MS and their
quantification was achieved using their corresponding standard when available, or their
aglycone or most similar phenolic structure otherwise. The daily phenolic dose provided by
SCP corresponds approximately to the intake of 112 g of fresh fruit (equivalent to two
servings).<table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Phenolic composition of experimental beverages (Mean values and standard
deviations)</p></caption><alternatives><graphic xlink:href="S0007114517000393_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">SCP</th><th align="center" rowspan="1" colspan="2">Control</th></tr><tr><th align="left" rowspan="1" colspan="1">Phenolic composition (&#x000b5;g/120 ml)</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Proanthocyanidins</td><td align="char" char="." rowspan="1" colspan="1">20 040<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">522</td><td align="char" char="." rowspan="1" colspan="1">5070</td><td align="char" char="." rowspan="1" colspan="1">169</td></tr><tr><td align="left" rowspan="1" colspan="1"> Monomers</td><td align="char" char="." rowspan="1" colspan="1">4156<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">1276</td><td align="char" char="." rowspan="1" colspan="1">36</td></tr><tr><td align="left" rowspan="1" colspan="1"> Dimers</td><td align="char" char="." rowspan="1" colspan="1">237</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1"> Polymers</td><td align="char" char="." rowspan="1" colspan="1">15 647<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">528</td><td align="char" char="." rowspan="1" colspan="1">3794</td><td align="char" char="." rowspan="1" colspan="1">133</td></tr><tr><td align="left" rowspan="1" colspan="1">Phenolic acids</td><td align="char" char="." rowspan="1" colspan="1">28 206<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">256</td><td align="char" char="." rowspan="1" colspan="1">5013</td><td align="char" char="." rowspan="1" colspan="1">138</td></tr><tr><td align="left" rowspan="1" colspan="1"> Gallic acid</td><td align="char" char="." rowspan="1" colspan="1">728<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"> Hydroxybenzoic acid</td><td align="char" char="." rowspan="1" colspan="1">3334<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">94</td><td align="char" char="." rowspan="1" colspan="1">103</td><td align="char" char="." rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>-Coumaric acid</td><td align="char" char="." rowspan="1" colspan="1">9095<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">171</td><td align="char" char="." rowspan="1" colspan="1">47</td><td align="char" char="." rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>m</italic>-Coumaric acid</td><td align="char" char="." rowspan="1" colspan="1">2051<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">80</td><td align="char" char="." rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"> Caffeic acid</td><td align="char" char="." rowspan="1" colspan="1">372</td><td align="char" char="." rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1"> Ferulic acid</td><td align="char" char="." rowspan="1" colspan="1">65<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1"> Vanillic acid</td><td align="char" char="." rowspan="1" colspan="1">107<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td></tr><tr><td align="left" rowspan="1" colspan="1"> Caffeoyl glucoside</td><td align="char" char="." rowspan="1" colspan="1">1282<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">54</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"> Coumaroyl glucoside</td><td align="char" char="." rowspan="1" colspan="1">5508<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">178</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1"> Chlorogenic acid</td><td align="char" char="." rowspan="1" colspan="1">927<xref ref-type="fn" rid="tab1fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">240</td><td align="char" char="." rowspan="1" colspan="1">28</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>SCP, strawberry and cranberry polyphenols; ND, not detectable/below limit of
detection.</p><p>The SCP beverage provided an average daily dose of 333 (<sc>sd</sc> 12) mg of
polyphenols, as determined by Folin&#x02013;Ciocalteu assay.</p></fn><fn id="tab1fn1"><label>*</label><p>Welch&#x02019;s <italic>t</italic> test and the Mann&#x02013;Whitney test showed significant
differences (<italic>P</italic>&#x0003c;0&#x000b7;05) in concentrations of each measured
phenolic compound in SCP beverage compared with Control.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="sec1-4" sec-type="general"><title>Study timeline</title><p>Participants were equally divided into two groups by sex after a 2-week run-in period.
During this period, subjects were asked to maintain their usual food habits and physical
activity level, and were limited to one unit drink or less of beer or spirits per day. The
consumption of berries, wine, polyphenol supplements and all products containing berries
or wine was also forbidden. Assignment of treatment was conducted through the use of a
random sequence of numbers. Allocation to treatment was concealed by a secure
computer-assisted method enabling preservation of assignments until enrolment was assured
and confirmed. Men and women were equally distributed among the two groups using the same
computer-assisted method. The study sponsor held the trial codes which were disclosed
after completion of the statistical analyses. Participants in the treatment group consumed
an SCP-containing beverage, whereas the Control group received a flavour-matched SCP-free
Control beverage, daily for a 6-week period. During the experimental period, subjects were
asked to follow the same aforementioned recommendations as during the run-in period.
Approximately 2&#x02013;3 weeks after the beginning of the experimental period, a registered
dietitian called all participants once to ensure that they consumed the beverages daily
and followed the prescribed instructions. Subjects were instructed to shake the bottle
before consumption and drink the beverage with or without food regardless of the time of
day. To document compliance, subjects were requested to bring back the unused bottles at
the end of the study. Bottle counts indicated a 99 % compliance in both groups. Also, a
6-week checklist was provided to all participants to identify study materials that had not
been ingested, thus providing us with a tool to confirm the compliance rate of the
participants.</p></sec><sec id="sec1-5" sec-type="general"><title>Anthropometric and blood pressure measurements</title><p>Fasted body weight, height, waist and hip circumferences were measured at the beginning
and at the end of the study using standardised methods. BMI and waist:hip ratio were then
calculated. Blood pressure was measured three times on the right arm with an automatic
tensiometer (Digital Blood Pressure Monitor, model HEM-907XL; OMRON<sup>&#x000ae;</sup>) following
a 10-min rest at the beginning and at the end of the experimental period.</p></sec><sec id="sec1-6" sec-type="general"><title>Food records and questionnaires</title><p>During the screening visit, two online self-administered questionnaires were completed by
all subjects to collect information on medical history, lifestyle, economic and
socio-demographic characteristics. Participants were also asked to complete two online
self-administered questionnaires at the beginning and at the end of the experimental
period, including a validated FFQ to record energy and macronutrient intake for 28
consecutive days<sup>(</sup>
<xref rid="ref26" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>)</sup> and a short physical activity questionnaire. There was also an additional
questionnaire on the subjects&#x02019; liking of the experimental beverages (taste, texture, etc.)
and on side effects, administered at the end of the study. Changes in medication,
temporary medication, natural health products intake or consumption of any other food
supplements were monitored according to the exclusion criteria during the entire study
period.</p></sec><sec id="sec1-7" sec-type="general"><title>Hyperinsulinaemic-euglycaemic clamp</title><p>A 120-min hyperinsulinaemic-euglycaemic clamp was performed at the beginning and at the
end of the experimental period at the Diabetes Research Unit of the Laval University
Health Center of Quebec after a 12-h overnight fast, according to the method described by
Piche <italic>et al</italic>.<sup>(</sup>
<xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>)</sup>. Alcohol intake was forbidden 48 h before the clamp. Insulin sensitivity
(<italic>M/I</italic>) was calculated from glucose infusion rate (mg/min) during the
final 30 min of the clamp divided by body weight (kg) and then divided by the mean insulin
concentration during the final 30 min of the clamp (mg/kg per min per pmol)<sup>(</sup>
<xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>)</sup>. For NEFA analysis, additional blood samples were collected during the clamp
at 0, 30, 60, 90 and 120 min, centrifuged after 30 min at room temperature and then stored
at &#x02212;80&#x000b0;C until analysis.</p></sec><sec id="sec1-8" sec-type="general"><title>Oral glucose tolerance test</title><p>A 75-g OGTT was performed 2&#x02013;3 d before each clamp at the beginning and at the end of the
experimental period at INAF to assess glucose tolerance after a 12-h overnight fast. Blood
samples were collected at time points &#x02212;15, 0, 15, 30, 60 and 120 min, immediately
centrifuged and kept at &#x02212;20&#x000b0;C for further measurements of glucose, insulin and C-peptide.
Alcohol intake was forbidden 48 h before the test. For the second clamp and OGTT,
participants were asked to consume the beverage 12 h before their appointment.</p></sec><sec id="sec1-9" sec-type="general"><title>Blood collection and storage</title><p>Plasma and serum samples were collected in the fasting state, before each OGTT and clamp,
and stored at &#x02212;80&#x000b0;C for further analysis of lipids, inflammatory markers (high-sensitivity
C-reactive protein (hsCRP), IL-6, TNF-<italic>&#x003b1;</italic>, high molecular weight (HMW)
adiponectin and regulated on activation normal T cell expressed and secreted
(RANTES)/chemokine ligand 5 (CCL5)), plasminogen activator inhibitor-1 (PAI-1), a marker
of cardiovascular risk, and ferric reducing antioxidant power (FRAP) and oxidised LDL,
markers of oxidative stress.</p></sec><sec id="sec1-10" sec-type="general"><title>Glucose, insulin and C-peptide</title><p>Plasma glucose was determined using an enzymatic method<sup>(</sup>
<xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>)</sup> and plasma insulin was measured by RIA with polyethylene glycol
separation<sup>(</sup>
<xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup>. Plasma C-peptide level, an indicator of insulin secretion used to estimate
pancreatic <italic>&#x003b2;</italic>-cell function, was determined using a modified version of
the method of Hedging with polyclonal antibody A-4741 from Ventrex and polyethylene glycol
precipitation<sup>(</sup>
<xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-11" sec-type="general"><title>Lipids</title><p>LDL and HDL were isolated from fresh blood by ultracentrifugation combined with a
heparin&#x02013;manganese chloride precipitation<sup>(</sup>
<xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref>
<sup>)</sup>. Then, cholesterol and TAG concentrations in total serum and lipoproteins
were determined enzymatically by using a Technicon RA-500 analyzer (Bayer). NEFA were
determined in serum via an enzymatic colorimetric assay (Wko Diagnostics) using a Beckman
Olympus AU400 (Beckman Coulter Canada LP).</p></sec><sec id="sec1-12" sec-type="general"><title>Inflammatory, thrombogenic and oxidative markers</title><p>Serum level of hsCRP was measured using nephelometry as described previously<sup>(</sup>
<xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref>
<sup>)</sup>. PAI-1, IL-6 and TNF-<italic>&#x003b1;</italic> were measured in plasma at the Quebec
Heart and Lung Institute, Quebec, using commercially available Multiplex kits (EMD
Millipore). Plates were read and analysed using the Bio-Plex 200 system (Bio-Rad).
Oxidised-LDL, HMW adiponectin and RANTES were determined using a commercially available
ELISA (Mercodia; R&#x00026;D Systems) according to manufacturer&#x02019;s instructions. Total
antioxidant capacity of plasma, assessed by FRAP assay, was determined as described
previously<sup>(</sup>
<xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-13" sec-type="general"><title>Bioavailability study</title><p>A subgroup of seventeen subjects performed an additional bioavailability study, to
identify circulating phenolic metabolites following the administration of experimental
beverages. Halfway through the supplementation period (30 (<sc>sem</sc> 3) d), fasted
subjects were administered their respective treatment at INAF (SCP, <italic>n</italic> 8;
Control, <italic>n</italic> 9). Blood samples were collected using EDTA-containing
syringes before and 30, 60, 120, 240 and 360 min after the ingestion. During the
experiment, all subjects were kept fasted. Plasma samples were obtained by centrifugation
(3500 rpm, 10 min at 4&#x000b0;C). Plasma phenolic compounds were characterised by UHPLC&#x02013;MS/MS as
previously described<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>, with slight modifications. Acidified plasma samples (300 &#x000b5;l) were loaded
into preconditioned Waters OASIS HLB (Waters Ltd) &#x000b5;Elution plates 2 mg&#x02013;30 &#x000b5;m. The retained
phenolic compounds were eluted with 75 &#x000b5;l of acetone&#x02013;ultrapure water&#x02013;acetic acid solution
(70:29&#x000b7;5:0&#x000b7;5, v/v/v) in presence of rosmarinic acid as internal standard (1 &#x000b5;g/ml final
concentration). The eluted solutions were directly analysed by UHPLC&#x02013;MS/MS, using a Waters
Xevo TQD MS (Waters Ltd) coupled to a Waters Acquity UHPLC (Waters Ltd). Phenolic
metabolites were separated and identified as previously reported<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-14" sec-type="general"><title>Statistical analyses</title><p>We estimated sample size based on the primary endpoint of insulin sensitivity from data
published by Stull <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup> and Ouellet <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref>
<sup>)</sup>. For this purpose, we used the following values: an average difference in
changes from baseline (Post <italic>v</italic>. Pre) of 17&#x000d7;10<sup>&#x02212;3</sup> mg/kg per min
per pmol for insulin sensitivity between the SCP and Control groups after 6 weeks and an
estimated <sc>sd</sc> of 18. Power calculation at 80 % with a two-sided significance level
set at 0&#x000b7;05 showed that a minimum of forty subjects, twenty in each group, was required to
observe significant changes from baseline in insulin sensitivity between the SCP and
Control groups over a 6-week dietary intervention, taking into account 25 % expected
dropouts. Statistical analyses were performed using SAS 9.3 (SAS Institute).</p><p>Paired <italic>t</italic> tests were performed to compare changes from baseline (Post
<italic>v</italic>. Pre) within the same group. Because baseline insulin sensitivity was
correlated with <italic>M/I</italic> (<italic>r</italic>
<sub>s</sub>=0&#x000b7;50; <italic>n</italic> 39; <italic>P</italic>&#x0003c;0&#x000b7;001) only, PROC
MIXED for ANCOVA with baseline insulin sensitivity as covariate was used to compare the
changes in <italic>M/I</italic> between the two treatments. A two-way repeated-measures
ANOVA was applied for variables with repeated measures over time (glucose, insulin,
C-peptide and NEFA concentrations during the OGTT or clamp). In this model, no significant
time-by-treatment interaction was observed. Furthermore, positive incremental AUC (IAUC)
for glucose (mmol/l per min), insulin (pmol/l per min) and C-peptide (pmol/l per min) up
to 30 and 120 min were calculated using the trapezoid method with baseline value
corresponding to the fasting level (time point &#x02212;15 min of the OGTT). The percentage change
in IAUC ((IAUC post value&#x02212;IAUC pre value)&#x000d7;100/IAUC pre value) was also calculated. PROC
MIXED for a two-way ANOVA was used to compare changes from baseline for anthropometric and
blood pressure measurements, IAUC glucose, insulin and C-peptide during OGTT, lipid and
cardiovascular parameters and markers of inflammation and oxidative stress. Data from men
and women were pooled together because there was no significant sex-by-treatment
interaction. As several significant correlations were observed within and between OGTT and
lipid variables, a Bonferroni correction was applied, setting the two-sided significance
level at <italic>P</italic>&#x0003c;0&#x000b7;004 for those variables. No Bonferroni correction was
applied for <italic>M/I,</italic> inflammatory and oxidative stress because no correlation
was observed between those and the other variables, and a two-sided significance level was
set at 0&#x000b7;05. PROC GLM ANOVA was used to compare the FFQ variables.</p><p>Plasma concentrations of phenolic metabolites were measured post-ingestion in a subgroup
(<italic>n</italic> 17) and were compared using the Welch&#x02019;s <italic>t</italic> test
(correcting for unequal variance) when data were assumed to be normally distributed (or
met the criteria for normality after log transformation), or using the non-parametric
Mann&#x02013;Whitney test otherwise, using GraphPad Prism 6.05 software. Correlations were
assessed between circulating concentrations of phenolic metabolites (expressed as area
under the plasma concentration (n<sc>m</sc>) time (min) curve between 0 and 30 min after
the ingestion of the beverages) and changes in <italic>M/I</italic> and in outcomes of
OGTT (expressed as the percentage change in the IAUC for glucose, insulin and C-peptide
during the first 30 min of the OGTT). A robust regression with
<italic>M</italic>-estimations was adjusted using the procedure ROBUSTREG of SAS 9.4. To
perform an optimal selection of the model, the smallest Akaike criterion was deemed the
best model. Considering the small size of the subgroup and the multiplicity of analysis, a
Bonferroni correction (<italic>P</italic>&#x0003c;0&#x000b7;0025) was performed for post-ingestion
plasma concentration of phenolic metabolites. Bonferroni correction was also applied for
the correlational analysis with the outcomes of the first 30 min OGTT parameters
(<italic>P</italic>&#x0003c;0&#x000b7;017). Since <italic>M/I</italic> assesses insulin
sensitivity by hyperinsulinaemic-euglycaemic clamp, correlations with <italic>M/I</italic>
changes were analysed separately from the OGTT rate changes and remained at a
statistically significant level of <italic>P</italic>&#x02264;0&#x000b7;05. The results are presented as
means with their standard errors.</p></sec></sec><sec sec-type="results" id="sec2"><title>Results</title><sec id="sec2-1" sec-type="general"><title>Subject baseline characteristics</title><p>Baseline clinical and laboratory characteristics of participants are shown in <xref ref-type="table" rid="tab2">Table 2</xref>. All subjects were insulin resistant,
overweight or obese (BMI&#x02265;25 kg/m<sup>2</sup>) with increased abdominal adiposity (waist
circumference &#x0003e;94 cm for men and &#x0003e;80 cm for women). There were no
differences between the two groups regarding age, body weight, BMI, waist and hip
circumferences, lipid profile, fasting plasma glucose, 2-h plasma glucose or fasting
plasma insulin.<table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Baseline characteristics of the study participants<xref ref-type="fn" rid="tab2fn1">*</xref> (Mean values with their standard errors; numbers and percentages)</p></caption><alternatives><graphic xlink:href="S0007114517000393_tab2"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">SCP (<italic>n</italic> 20)</th><th align="center" rowspan="1" colspan="2">Control (<italic>n</italic> 21)</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="char" char="." rowspan="1" colspan="1">57</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">60</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td align="char" char="." rowspan="1" colspan="1">85</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">85</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;97</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="char" char="." rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;91</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="char" char="." rowspan="1" colspan="1">104</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">104</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;95</td></tr><tr><td align="left" rowspan="1" colspan="1">Hip circumference (cm)</td><td align="char" char="." rowspan="1" colspan="1">111</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">111</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;93</td></tr><tr><td align="left" rowspan="1" colspan="6">Cholesterol (mmol/l)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Total</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;70</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;07</td></tr><tr><td align="left" rowspan="1" colspan="1"> HDL</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td></tr><tr><td align="left" rowspan="1" colspan="1"> LDL</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td></tr><tr><td align="left" rowspan="1" colspan="1">Total TAG (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;73</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;39</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol:HDL-cholesterol ratio</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;07</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting plasma glucose (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;16</td></tr><tr><td align="left" rowspan="1" colspan="1">2-h plasma glucose (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;71</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting plasma insulin (pmol/l)</td><td align="char" char="." axis="0" rowspan="1" colspan="1">118</td><td align="char" char="." axis="0" rowspan="1" colspan="1">11</td><td align="char" char="." axis="0" rowspan="1" colspan="1">130</td><td align="char" char="." axis="0" rowspan="1" colspan="1">11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;45</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<italic>n</italic>
</td><td align="center" rowspan="1" colspan="1">%</td><td align="center" rowspan="1" colspan="1">
<italic>n</italic>
</td><td align="center" rowspan="1" colspan="1">%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Women</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">55</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"> Men</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">45</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>SCP, strawberry and cranberry polyphenols.</p></fn><fn id="tab2fn1"><label>*</label><p>PROC MIXED ANOVA test showed no significant differences in baseline
characteristics between the two groups.</p></fn></table-wrap-foot></table-wrap>
</p><p>At baseline, all subjects had a high fasting plasma insulin level (&#x0003e;60 pmol/l), of
whom thirty-one had fasting plasma insulin levels &#x0003e;90 pmol/l. From data collected
during the pre-intervention OGTT and according to the Expert Committee on the Diagnosis
and Classification of Diabetes Mellitus<sup>(</sup>
<xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>)</sup>, twelve subjects had both IFG (5&#x000b7;6&#x02013;6&#x000b7;9 mmol/l) and IGT (7&#x000b7;8&#x02013;11&#x000b7;0 mmol/l),
seventeen subjects had IFG only, three subjects had IGT only and nine among them had
normal glucose tolerance (fasting plasma glucose &#x0003c;5&#x000b7;6 mmol/l and plasma glucose
&#x0003c;7&#x000b7;8 mmol/l after 120 min).</p></sec><sec id="sec2-2" sec-type="general"><title>Food intake and physical activity</title><p>According to FFQ data (online Supplementary Table S1), there were no differences in
baseline dietary intake or in changes from baseline (Post <italic>v</italic>. Pre) in
energy and macronutrient intake between the two groups. In addition, no change from the
level of physical activity was perceived during the study (data not shown). As for side
effects, no major harmful or unexpected effects were reported in either group.</p></sec><sec id="sec2-3" sec-type="general"><title>Anthropometric measurements and blood pressure</title><p>Body weight, anthropometric, systolic and diastolic blood pressure measurements were
performed at the beginning and at the end of the experimental period. No differences in
changes from baseline (Post <italic>v</italic>. Pre) were observed for these parameters
between the two groups (online Supplementary Table S2).</p></sec><sec id="sec2-4" sec-type="general"><title>Insulin sensitivity and other parameters of glucose homoeostasis</title><p>Insulin sensitivity (<italic>M/I</italic>) increased by 14 % (+0&#x000b7;9 (<sc>sem</sc>
0&#x000b7;5)&#x000d7;10<sup>&#x02212;3</sup> mg/kg per min per pmol) (<xref ref-type="fig" rid="fig1">Fig.
1</xref>) in the SCP group (<italic>P</italic>=0&#x000b7;05), whereas it decreased by 7 % (&#x02212;0&#x000b7;5
(<sc>sem</sc> 0&#x000b7;5)&#x000d7;10<sup>&#x02212;3</sup> mg/kg per min per pmol) in the Control group without
achieving a level of significance (<italic>P</italic>=0&#x000b7;28). When we compared the changes
from baseline (Post <italic>v</italic>. Pre) between the two treatments, the SCP group
showed significant improvement in insulin sensitivity (<italic>P</italic>=0&#x000b7;03) compared
with Control.<fig id="fig1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Insulin sensitivity (<italic>M/I</italic>) before (Pre) and after (Post) 6-week
consumption of strawberry and cranberry polyphenols (SCP) or Control in
insulin-resistant human subjects. Values are means (<italic>n</italic> 39), with
their standard errors represented by vertical bars. NS, no significant difference.
Paired <italic>t</italic> test for comparisons from baseline (Post
<italic>v</italic>. Pre) within each group showed a significant increase with SCP, &#x02020;
<italic>P</italic>=0&#x000b7;05. PROC MIXED for ANCOVA with baseline insulin sensitivity
as covariate indicated significant difference in changes from baseline (Post
<italic>v</italic>. Pre) between the two groups, * <italic>P</italic>=0&#x000b7;03.</p></caption><graphic xlink:href="S0007114517000393_fig1"/></fig>
</p><p>We also performed repeated measurements ANOVA for glucose (<xref ref-type="table" rid="tab3">Table 3</xref>), insulin (<xref ref-type="table" rid="tab3">Table 3</xref>)
and C-peptide (<xref ref-type="fig" rid="fig2">Fig. 2(a) and (b)</xref>) up to 120 min
during OGTT and for NEFA (online Supplementary Fig. S2) over time during the clamp. There
were no differences between baseline values (Pre) for all glucose metabolism parameters.
Whereas glucose, insulin and NEFA responses were not different between treatments, there
was an overall increase in C-peptide with Control compared with SCP
(<italic>P</italic>=0&#x000b7;002) (<xref ref-type="fig" rid="fig2">Fig. 2(c)</xref>).<fig id="fig2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Responses of plasma C-peptide at &#x02212;15, 0, 15, 30, 60 and 120 min during the oral
glucose tolerance test (OGTT) before (Pre) and after (Post) 6-week consumption of
(a) strawberry and cranberry polyphenols (SCP) or (b) Control, in insulin-resistant
human subjects. (c) Changes from baseline (Post <italic>v</italic>. Pre) in plasma
C-peptide at &#x02212;15, 0, 15, 30, 60 and 120 min during the OGTT before (Pre) and after
(Post) 6-week consumption of SCP or Control in insulin-resistant human subjects.
Repeated measures ANOVA showed significant difference in the changes from baseline
(Post <italic>v</italic>. Pre) between the two groups over time during the OGTT in
insulin-resistant human subjects. A Bonferroni correction was applied defining level
of statistical significance at <italic>P</italic>&#x0003c;0&#x000b7;004. Values are means
(<italic>n</italic> 41), with their standard errors represented by vertical bars.
<inline-graphic xlink:href="S0007114517000393_inline1.jpg" mime-subtype="gif"/>, SCP Pre values; <inline-graphic xlink:href="S0007114517000393_inline2.jpg" mime-subtype="gif"/>,
SCP Post values; <inline-graphic xlink:href="S0007114517000393_inline3.jpg" mime-subtype="gif"/>, Control Pre values; <inline-graphic xlink:href="S0007114517000393_inline4.jpg" mime-subtype="gif"/>,
Control Post values; <inline-graphic xlink:href="S0007114517000393_inline5.jpg" mime-subtype="gif"/>, SCP (Post <italic>v</italic>. Pre
values); <inline-graphic xlink:href="S0007114517000393_inline6.jpg" mime-subtype="gif"/>, Control (Post <italic>v</italic>. Pre
values).</p></caption><graphic xlink:href="S0007114517000393_fig2"/></fig>
<table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Incremental AUC (IAUC) and time point values over time during oral glucose
tolerance test (OGTT) for glucose and insulin before and after 6-week consumption of
strawberry and cranberry polyphenols (SCP) or Control in insulin-resistant human
subjects (Mean values with their standard errors)</p></caption><alternatives><graphic xlink:href="S0007114517000393_tab3"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="4">SCP (<italic>n</italic> 20)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="5">Control (<italic>n</italic> 21)</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Pre</th><th align="center" rowspan="1" colspan="2">Post</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Pre</th><th align="center" rowspan="1" colspan="2">Post</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<sub>1</sub>
<xref ref-type="fn" rid="tab3fn1">*</xref>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<sub>2</sub>
<xref ref-type="fn" rid="tab3fn1">*</xref>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<xref ref-type="fn" rid="tab3fn2">&#x02020;</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IAUC glucose up to 30 min (mmol/l per
min)</td><td align="char" char="." rowspan="1" colspan="1">56</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">58</td><td align="char" char="." rowspan="1" colspan="1">6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;77</td><td align="char" char="." rowspan="1" colspan="1">55</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">53</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;48</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;77</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma glucose (mmol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;42</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;53</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;31<xref ref-type="fn" rid="tab3fn3">&#x02021;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> &#x02212;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 30</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 120</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IAUC glucose up to 120 min (mmol/l per
min)</td><td align="char" char="." rowspan="1" colspan="1">348</td><td align="char" char="." rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">357</td><td align="char" char="." rowspan="1" colspan="1">32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;71</td><td align="char" char="." rowspan="1" colspan="1">329</td><td align="char" char="." rowspan="1" colspan="1">34</td><td align="char" char="." rowspan="1" colspan="1">291</td><td align="char" char="." rowspan="1" colspan="1">27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;16</td></tr><tr><td align="left" rowspan="1" colspan="1">IAUC insulin up to 30 min (pmol/l per
min)</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;56</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma insulin (pmol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;41</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;34</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21<xref ref-type="fn" rid="tab3fn3">&#x02021;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> &#x02212;15</td><td align="char" char="." rowspan="1" colspan="1">129</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">132</td><td align="char" char="." rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">134</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">144</td><td align="char" char="." rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 0</td><td align="char" char="." rowspan="1" colspan="1">118</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">120</td><td align="char" char="." rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">130</td><td align="char" char="." rowspan="1" colspan="1">13</td><td align="char" char="." rowspan="1" colspan="1">131</td><td align="char" char="." rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 15</td><td align="char" char="." rowspan="1" colspan="1">402</td><td align="char" char="." rowspan="1" colspan="1">37</td><td align="char" char="." rowspan="1" colspan="1">418</td><td align="char" char="." rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">479</td><td align="char" char="." rowspan="1" colspan="1">58</td><td align="char" char="." rowspan="1" colspan="1">600</td><td align="char" char="." rowspan="1" colspan="1">85</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 30</td><td align="char" char="." rowspan="1" colspan="1">729</td><td align="char" char="." rowspan="1" colspan="1">73</td><td align="char" char="." rowspan="1" colspan="1">645</td><td align="char" char="." rowspan="1" colspan="1">76</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">759</td><td align="char" char="." rowspan="1" colspan="1">79</td><td align="char" char="." rowspan="1" colspan="1">822</td><td align="char" char="." rowspan="1" colspan="1">106</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 60</td><td align="char" char="." rowspan="1" colspan="1">1006</td><td align="char" char="." rowspan="1" colspan="1">99</td><td align="char" char="." rowspan="1" colspan="1">968</td><td align="char" char="." rowspan="1" colspan="1">104</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">1173</td><td align="char" char="." rowspan="1" colspan="1">148</td><td align="char" char="." rowspan="1" colspan="1">1064</td><td align="char" char="." rowspan="1" colspan="1">127</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> 120</td><td align="char" char="." rowspan="1" colspan="1">895</td><td align="char" char="." rowspan="1" colspan="1">111</td><td align="char" char="." rowspan="1" colspan="1">818</td><td align="char" char="." rowspan="1" colspan="1">99</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">1094</td><td align="char" char="." rowspan="1" colspan="1">184</td><td align="char" char="." rowspan="1" colspan="1">1208</td><td align="char" char="." rowspan="1" colspan="1">233</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IAUC insulin up to 120 min (pmol/l per
min)</td><td align="char" char="." rowspan="1" colspan="1">80</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">74</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;40</td><td align="char" char="." rowspan="1" colspan="1">95</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">95</td><td align="char" char="." rowspan="1" colspan="1">13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;94</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;51</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="tab3fn1"><label>*</label><p>
<italic>P</italic> value obtained from paired <italic>t</italic> test to compare
changes from baseline (Post <italic>v</italic>. Pre) within the SCP (<italic>P</italic>
<sub>1</sub>) and Control (<italic>P</italic>
<sub>2</sub>) groups.</p></fn><fn id="tab3fn2"><label>&#x02020;</label><p>
<italic>P</italic> value represents between-treatment comparison of changes from
baseline (Post <italic>v</italic>. Pre), assessed by PROC MIXED ANOVA.</p></fn><fn id="tab3fn3"><label>&#x02021;</label><p>
<italic>P</italic> value obtained from repeated measures ANOVA performed on the
averages of all time points for SCP and Control to assess treatment effect. Due to
significant correlations within OGTT variables, a Bonferroni correction was
applied for these variables, defining level of statistical significance at
<italic>P</italic>&#x0003c;0&#x000b7;004.</p></fn></table-wrap-foot></table-wrap>
</p><p>The mean IAUC up to 30 min corresponding to the early phase of insulin response during
the OGTT and the mean IAUC up to 120 min after the OGTT are shown in <xref ref-type="table" rid="tab3">Table 3</xref> for plasma glucose and insulin and in <xref ref-type="fig" rid="fig3">Fig. 3</xref> and <xref ref-type="fig" rid="fig4">4</xref> for
C-peptide. No differences in changes from baseline (Post <italic>v</italic>. Pre) for
plasma IAUC glucose (<xref ref-type="table" rid="tab3">Table 3</xref>), IAUC insulin
(<xref ref-type="table" rid="tab3">Table 3</xref>) and IAUC C-peptide (<xref ref-type="fig" rid="fig3">Fig. 3</xref>) were observed up to 120 min within each group
or between the two groups. However, compared with the baseline (Pre) values, plasma IAUC
C-peptide up to 30 min was increased by 26 % in the Control group
(<italic>P</italic>=0&#x000b7;003) and non-significantly reduced by 8 % in the SCP group
(<italic>P</italic>=0&#x000b7;21). These changes were different between the two groups
(<italic>P</italic>=0&#x000b7;002) (<xref ref-type="fig" rid="fig4">Fig. 4</xref>).<fig id="fig3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Positive incremental AUC (IAUC) up to 120 min of the oral glucose tolerance test
for C-peptide concentrations before (Pre) and after (Post) 6-week consumption of
strawberry and cranberry polyphenols (SCP) or Control in insulin-resistant human
subjects. Values are means (<italic>n</italic> 41), with their standard errors
represented by vertical bars. Paired <italic>t</italic> test showed no difference in
changes from baseline (Post <italic>v</italic>. Pre) in the SCP and Control groups.
PROC MIXED for a two-way ANOVA showed no significant effect in the changes from
baseline (Post <italic>v</italic>. Pre) between the two groups.</p></caption><graphic xlink:href="S0007114517000393_fig3"/></fig>
<fig id="fig4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Positive incremental AUC (IAUC) up to 30 min of the oral glucose tolerance test for
C-peptide concentrations before (Pre) and after (Post) 6-week consumption of
strawberry and cranberry polyphenols (SCP) or Control in insulin-resistant human
subjects. Values are means (<italic>n</italic> 41), with their standard errors
represented by vertical bars. NS, no significant difference. Paired
<italic>t</italic> test for comparisons from baseline (Post <italic>v</italic>. Pre)
within each group showed a significant increase with Control, &#x02020;
<italic>P</italic>=0&#x000b7;003. PROC MIXED for a two-way ANOVA showed a significant
difference in the changes from baseline (Post <italic>v</italic>. Pre) between the
two groups, * <italic>P</italic>=0&#x000b7;002.</p></caption><graphic xlink:href="S0007114517000393_fig4"/></fig>
</p></sec><sec id="sec2-5" sec-type="general"><title>Lipid profile</title><p>No differences in changes from baseline (Post <italic>v</italic>. Pre) for total, LDL-
and HDL-cholesterol or TAG were observed within each group or between the two groups
(<xref ref-type="table" rid="tab4">Table 4</xref>).<table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Lipid profile, inflammatory and thrombogenic markers, and oxidative status before
and after 6-week consumption of strawberry and cranberry polyphenols (SCP) or
Control in insulin-resistant human subjects (Mean values with their standard
errors)</p></caption><alternatives><graphic xlink:href="S0007114517000393_tab4"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="4">SCP (<italic>n</italic> 20)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="4">Control (<italic>n</italic> 21)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Pre</th><th align="center" rowspan="1" colspan="2">Post</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Pre</th><th align="center" rowspan="1" colspan="2">Post</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<sub>1</sub>
<xref ref-type="fn" rid="tab4fn1">*</xref>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sem</sc>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<sub>2</sub>
<xref ref-type="fn" rid="tab4fn1">*</xref>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<xref ref-type="fn" rid="tab4fn2">&#x02020;</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="12">Cholesterol (mmol/l)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Total</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;70</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;33</td></tr><tr><td align="left" rowspan="1" colspan="1"> HDL</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;06</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;68</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;06</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;10</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;40</td></tr><tr><td align="left" rowspan="1" colspan="1"> LDL</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;51</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;97</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol:HDL-cholesterol ratio</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;76</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;62</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;16</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;41</td></tr><tr><td align="left" rowspan="1" colspan="1">TAG (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;82</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;06</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;73</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;56</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;07</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;99</td></tr><tr><td align="left" rowspan="1" colspan="1">hsCRP (mg/l)<xref ref-type="fn" rid="tab4fn3">&#x02021;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;69</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;53</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF-<italic>&#x003b1;</italic> (ng/l)<xref ref-type="fn" rid="tab4fn4">&#x000a7;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;06</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;69</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-6 (ng/l)<xref ref-type="fn" rid="tab4fn4">&#x000a7;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;99</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td></tr><tr><td align="left" rowspan="1" colspan="1">HMW adiponectin (&#x000b5;g/ml)<xref ref-type="fn" rid="tab4fn4">&#x000a7;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;83</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;10</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;91</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;93</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;73</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;61</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;65</td></tr><tr><td align="left" rowspan="1" colspan="1">PAI-1&#x000d7;10<sup>3</sup> (ng/l)<xref ref-type="fn" rid="tab4fn4">&#x000a7;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">30&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">28&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;46</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">30&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">27&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;41</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;87</td></tr><tr><td align="left" rowspan="1" colspan="1">RANTES (&#x000b5;g/l)<xref ref-type="fn" rid="tab4fn3">&#x02021;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;39</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;44</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;86</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;06</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;40</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;77</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;53</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;71</td></tr><tr><td align="left" rowspan="1" colspan="1">Oxidised-LDL (U/l)<xref ref-type="fn" rid="tab4fn3">&#x02021;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">96&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">92&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">79&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">80&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;83</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td></tr><tr><td align="left" rowspan="1" colspan="1">FRAP (&#x000b5;<sc>m</sc>
Fe<sup>2+</sup>/l)<xref ref-type="fn" rid="tab4fn3">&#x02021;</xref>
</td><td align="char" char="." rowspan="1" colspan="1">1191</td><td align="char" char="." rowspan="1" colspan="1">58</td><td align="char" char="." rowspan="1" colspan="1">1237</td><td align="char" char="." rowspan="1" colspan="1">65</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;37</td><td align="char" char="." rowspan="1" colspan="1">1135</td><td align="char" char="." rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">1189</td><td align="char" char="." rowspan="1" colspan="1">41</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;07</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;70</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>hsCRP, high-sensitivity C-reactive protein; HMW, high molecular weight; PAI-1,
plasminogen activator inhibitor-1; RANTES, regulated on activation, normal T cell
expressed and secreted; FRAP, ferric reducing antioxidant power.</p></fn><fn id="tab4fn1"><label>*</label><p>
<italic>P</italic> value obtained from paired <italic>t</italic> test to compare
changes from baseline (Post <italic>v</italic>. Pre) within the SCP (<italic>P</italic>
<sub>1</sub>) and Control (<italic>P</italic>
<sub>2</sub>) groups.</p></fn><fn id="tab4fn2"><label>&#x02020;</label><p>
<italic>P</italic> value represents between-treatment comparison of changes from
baseline (Post <italic>v</italic>. Pre), assessed by PROC MIXED ANOVA. Due to
significant correlations between lipid and oral glucose tolerance test variables,
a Bonferroni correction was applied for these variables, defining level of
statistical significance at <italic>P</italic>&#x0003c;0&#x000b7;004.</p></fn><fn id="tab4fn3"><label>&#x02021;</label><p>
<italic>n</italic> 38&#x02013;39 (SCP <italic>n</italic> 18&#x02013;20; Control <italic>n</italic>
18&#x02013;21).</p></fn><fn id="tab4fn4"><label>&#x000a7;</label><p>
<italic>n</italic> 33 (SCP <italic>n</italic> 15; Control <italic>n</italic>
18).</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="sec2-6" sec-type="general"><title>Inflammatory, thrombogenic and oxidative markers</title><p>The effects of SCP on inflammatory and oxidative stress markers are shown in <xref ref-type="table" rid="tab4">Table 4</xref>. No differences in changes from baseline
(Post <italic>v</italic>. Pre) for pro-inflammatory cytokines, hsCRP, HMW adiponectin,
PAI-1, oxidised-LDL, RANTES or total antioxidant capacity of plasma (FRAP) were observed
within each group or between the two groups.</p></sec><sec id="sec2-7" sec-type="general"><title>Phenolic composition and bioavailability of experimental beverages</title><p>As shown in <xref ref-type="table" rid="tab1">Table 1</xref>, SCP-containing and SCP-free
Control beverages differed significantly in terms of phenolic content. SCP contained four
times more proanthocyanidins and six times more phenolic acids. In particular, SCP were
characterised by a very high content of coumaric acids: <italic>p</italic>-coumaric acid,
<italic>m</italic>-coumaric acid and coumaroyl glucoside. At the 30-d midpoint of the
daily consumption of the beverages, about twenty phenolic metabolites were identified in
the plasma of volunteers. They are present in circulation as conjugate metabolites and
microbial degradation products, because the native phenolic compounds are normally
extensively metabolised. Among these, <italic>p</italic>-coumaric acid,
<italic>m</italic>-coumaric acid, ferulic acid and hydroxyhippuric acid, whose absorption
kinetics is presented in <xref ref-type="fig" rid="fig5">Fig. 5</xref>, were detected in
significantly higher concentration following the consumption of SCP, relative to Control
(respective AUC of 17&#x000b7;4 (<sc>sem</sc> 1&#x000b7;8) <italic>v</italic>. 0, 85&#x000b7;9 (<sc>sem</sc> 5&#x000b7;3)
<italic>v</italic>. 0&#x000b7;7 (<sc>sem</sc> 0&#x000b7;3), 20&#x000b7;3 (<sc>sem</sc> 3&#x000b7;9) <italic>v</italic>.
0&#x000b7;9 (<sc>sem</sc> 0&#x000b7;4), 204&#x000b7;6 (<sc>sem</sc> 25&#x000b7;4) <italic>v</italic>. 38&#x000b7;6 (<sc>sem</sc>
6&#x000b7;9); <italic>P</italic>&#x0003c;0&#x000b7;0001). A significant negative correlation was found
between plasma concentration of <italic>p</italic>-coumaric acid (AUC 0&#x02013;30 min) and the
percentage change in IAUC (before and after treatment) of the above-mentioned C-peptide
response (first 30 min of the OGTT) (<italic>P</italic>=0&#x000b7;0046, <italic>r</italic>
<sup>2</sup> 0&#x000b7;34). No correlations were reported between the remaining metabolites and
the parameters related to insulin sensitivity and the first 30 min OGTT.<fig id="fig5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Evolution of post-ingestion plasma concentrations of phenolic metabolites. (a)
<italic>p</italic>-coumaric acid, (b) <italic>m</italic>-coumaric acid, (c)
ferulic acid, (d) hydroxyhippuric acid. Values are mean of replicates
(<italic>n</italic> 17), with their standard errors. Welch&#x02019;s <italic>t</italic> test
(correcting for unequal variance) when data were assumed to be normally distributed
and the non-parametric Mann&#x02013;Whitney test otherwise, showed significantly higher
concentrations of phenolic metabolites following the consumption of strawberry and
cranberry polyphenols (SCP) relative to Control. A Bonferroni correction
(<italic>P</italic>&#x0003c;0&#x000b7;0025) was performed. <italic>P</italic>&#x0003c;0&#x000b7;0001
for each phenolic metabolite. <inline-graphic xlink:href="S0007114517000393_inline5.jpg" mime-subtype="gif"/>, SCP; <inline-graphic xlink:href="S0007114517000393_inline6.jpg" mime-subtype="gif"/>, Control.</p></caption><graphic xlink:href="S0007114517000393_fig5"/></fig>
</p></sec></sec><sec sec-type="discussion" id="sec3"><title>Discussion</title><p>This study investigated the impact of daily consumption of a 333 mg SCP blend on insulin
sensitivity in insulin-resistant, non-diabetic subjects over a period of 6 weeks. The main
outcomes of this study are: (1) an improvement in insulin sensitivity, as assessed by
hyperinsulinaemic-euglycaemic clamp and (2) the prevention of further compensatory insulin
secretion, as shown by a lack of increase in the early C-peptide response during an OGTT.
Analysis of plasma phenolic metabolites also revealed that the most abundant phenolic acids
identified with SCP intake were <italic>p</italic>-coumaric acid,
<italic>m</italic>-coumaric acid, ferulic acid and hydroxyhippuric acid. Interestingly,
plasma <italic>p</italic>-coumaric acid was inversely related to the early C-peptide
response during OGTT.</p><p>The hyperinsulinaemic-euglycaemic clamp is the gold standard and reference technique for
assessing insulin sensitivity when whole-body insulin sensitivity is the primary
outcome<sup>(</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup>. It is a steady-state technique that requires a constant insulin infusion. It
is the most reliable technique in a clinical study like ours with relatively low number of
subjects. Although indirect OGTT-derived indices (e.g. Matsuda index and ISI) may be of
particular interest in prospective studies with large cohorts, they have potential
limitations in reproducibility due to intra-individual variation in plasma glucose and
insulin responses during the OGTT<sup>(</sup>
<xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref>
<sup>)</sup>. With regard to the indirect indices based on fasting levels of glucose and
insulin (e.g. HOMA-IR and QUICKI), they tend to assess hepatic insulin resistance rather
than peripheral and whole-body insulin sensitivity<sup>(</sup>
<xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref>
<sup>)</sup>.</p><p>Our study demonstrates an improvement in insulin sensitivity following the consumption of
SCP compared with Control. These results are in good agreement with those of Stull
<italic>et al</italic>.<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup> who observed a 22 % increase in insulin sensitivity, assessed with the
hyperinsulinaemic-euglycaemic clamp technique, following a 6-week daily dietary
supplementation with whole blueberries in obese, non-diabetic, and insulin-resistant human
subjects, and those of Hokayem <italic>et al</italic>.<sup>(</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup> who noted that the negative effects of fructose used to develop insulin
resistance were counteracted by grape polyphenol supplementation in a double-blind
controlled trial. It is noteworthy that our dose of polyphenols (a total of 333 mg of
combined SCP/d), which is a much lower dose than those used by Stull <italic>et
al</italic>.<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup> (1462 mg polyphenols from blueberry powder/d) and Hokayem <italic>et
al</italic>.<sup>(</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup> (2 g from grape polyphenols/d), can exert a comparable effect on insulin
sensitivity. The present results with SCP are also in good agreement with those reported by
Edirisinghe <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref>
<sup>)</sup> who observed a reduction in postprandial insulin response in overweight adults
after a single consumption of a high-carbohydrate, moderate-fat meal with a strawberry
beverage containing 10 g of strawberries in a freeze-dried form (95 mg of polyphenols).
Furthermore, Park <italic>et al</italic>.<sup>(</sup>
<xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref>
<sup>)</sup> observed a reduction in systolic and diastolic blood pressure concomitant with
a trend to improve fasting insulin and insulin sensitivity in subjects with pre-hypertension
consuming a grape seed extract-containing beverage (528 mg of polyphenols). Most of these
subjects were hyperinsulinaemic or insulin resistant. This is of interest in the present
study, given the evidence supporting a link between hypertension and insulin resistance
through insulin mediated signalling pathways<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>)</sup> and NO production<sup>(</sup>
<xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref>
<sup>)</sup>. Similarly, Rodriguez-Mateos <italic>et al</italic>.<sup>(</sup>
<xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref>
<sup>)</sup> reported that endothelial function (at 1 h) in healthy men increased in a
dose-dependent manner up to an intake of 766 mg polyphenols from a blueberry drink and
reached a plateau at higher doses. Therefore, the present results together with those from
the three latter studies suggest that polyphenol doses lower than 800 mg may offer metabolic
benefits. Of note, the beneficial effect of SCP on insulin sensitivity observed in the
present study cannot be explained by variations in energy and macronutrient intake, body
weight or body fat mass since no changes in these parameters were seen between the two
groups.</p><p>The progression from normal glucose tolerance to type 2 diabetes is characterised by both
an increase in insulin resistance and a decrease in insulin secretion caused by
<italic>&#x003b2;</italic>-cell dysfunction. Insulin resistance is defined as decreased tissue
sensitivity to insulin to stimulate glucose uptake and utilisation. In the early stages of
insulin resistance, plasma glucose is maintained at normal levels by a compensatory increase
in insulin secretion, the first abnormality being an increase in first-phase insulin
secretion by pancreatic <italic>&#x003b2;</italic>-cells<sup>(</sup>
<xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref>
<sup>)</sup>. But when <italic>&#x003b2;</italic>-cell compensation fails, fasting plasma glucose
levels rise (IFG), leading to IGT and eventually type 2 diabetes<sup>(</sup>
<xref rid="ref42" ref-type="bibr">
<sup>42</sup>
</xref>
<sup>)</sup>. In the context of the present study, the beverage rich in polyphenols
prevented a further elevation in early-phase insulin release, as indicated by C-peptide
levels, and prevented the overall increase of insulin secretion, suggesting that the
improvement in insulin sensitivity after consumption of the SCP beverage may have precluded
a further compensatory increase in insulin secretion. A reducing effect of a polyphenol-rich
cranberry extract has already been observed on C-peptide levels in high-fat/high-sucrose-fed
mice<sup>(</sup>
<xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref>
<sup>)</sup>. However, in humans, to the best of our knowledge, this is the first report
showing a beneficial effect of a SCP extract on C-peptide response during an OGTT.</p><p>In this study, we found differences between the SCP and the Control groups in the plasma
levels of four polyphenolic compounds and metabolites (<italic>p</italic>-coumaric acid,
<italic>m</italic>-coumaric acid, ferulic acid, hydroxyhippuric acid). These levels were
found in the same low micromolar range as that reported by Feliciano <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref>
<sup>)</sup> and Park <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref>
<sup>)</sup>, where physiological and metabolic bioactivity is probable<sup>(</sup>
<xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref>
<sup>)</sup>. Particularly of interest, an increased plasma concentration of
<italic>p</italic>-coumaric acid during the 30 min post-consumption was found to
significantly correlate with a reduced secretion of C-peptide compared with the Control
during the early phase of the OGTT response (<italic>P</italic>=0&#x000b7;0046, <italic>r</italic>
<sup>2</sup> 0&#x000b7;34). Although a direct effect of <italic>p</italic>-coumaric acid on insulin
sensitivity cannot be confirmed by these results, this compound was recently found to
stimulate AMP-activated protein kinase phosphorylation, leading to increased glucose uptake
in L6 myocytes<sup>(</sup>
<xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref>
<sup>)</sup>. <italic>p</italic>-Coumaric acid was also found to improve glucose uptake
<italic>in vitro</italic> through synergistic interactions with a commercial oral
hypoglycaemic drug (thiazolidinedione)<sup>(</sup>
<xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref>
<sup>)</sup>. Moreover, since only 5&#x02013;10 % of ingested phenolic compounds are assumed to be
absorbed<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>)</sup>, a large amount proceeds to the large intestine (especially polymeric forms
such as proanthocyanidins) where they can exert an activity. Indeed, we recently showed that
cranberry polyphenols can improve insulin sensitivity in high-fat-fed mice, leading to
reduced inflammation in both intestinal and hepatic tissues, through modulation of gut
microbiota<sup>(</sup>
<xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref>
<sup>)</sup>. In this latter study, changes in gut microbiota were detected following 5
weeks of supplementation, suggesting that 6 weeks of supplementation in humans was very
likely a period long enough to modulate their intestinal microbiota. SCP may also improve
insulin sensitivity by increasing insulin signalling and glucose transport in skeletal
muscle cells. Indeed, Nizamutdinova <italic>et al</italic>.<sup>(</sup>
<xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>)</sup> showed that anthocyanins administrated by gavage can improve insulin signalling
by stimulating tyrosine phosphorylation of the insulin receptors and by increasing the
expression of GLUT4 in muscle of streptozotocin-diabetic rats.</p><p>Whereas our study provides evidence for the beneficial effect of SCP treatment on insulin
sensitivity, this finding was not associated with a decrease in other markers of
cardiovascular risk. Nutritional studies are somewhat contradictory regarding the effects of
strawberries and cranberries on cardiometabolic markers such as plasma lipids, oxidative
stress, antioxidant capacity and inflammation. Indeed, lipid changes seen in our study
contrast with those reported by Basu <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref8" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> and Lee <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref>
<sup>)</sup> who observed a decrease in total cholesterol and LDL-cholesterol in human
subjects consuming either freeze-dried strawberry powder<sup>(</sup>
<xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>)</sup> or cranberry extract<sup>(</sup>
<xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref>
<sup>)</sup>. Similarly, our findings on inflammatory and oxidative markers do not agree
with those of Moazen <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref50" ref-type="bibr">
<sup>50</sup>
</xref>
<sup>)</sup> who observed a decrease in plasma CRP and oxidised-LDL after administration of
freeze-dried strawberries, and those of Ruel <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref10" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>,</sup>
<xref rid="ref12" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>,</sup>
<xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref>
<sup>)</sup> who observed an increase of plasma HDL-cholesterol, antioxidant capacity and a
decrease in oxidised-LDL after consumption of low-energy cranberry drink. Additionally, some
clinical studies investigating the effects of approximately 300 mg polyphenols from
freeze-dried strawberry powder reported reducing effects on fasting oxidised LDL for 6
weeks<sup>(</sup>
<xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>)</sup>, and postprandial CRP and IL-6<sup>(</sup>
<xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref>
<sup>)</sup> in an overweight, hyperlipidaemic population. However, other clinical studies
using freeze-dried strawberry powder or reduced-energy cranberry juice have demonstrated, as
in our study, a lack of effect on antioxidant status<sup>(</sup>
<xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref>
<sup>)</sup>, on CRP, IL-6 and TNF-<italic>&#x003b1;</italic>
<sup>(</sup>
<xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref>
<sup>,</sup>
<xref rid="ref53" ref-type="bibr">
<sup>53</sup>
</xref>
<sup>)</sup>.</p><p>Discrepancies between our results on lipids and inflammatory and oxidative markers and
those of the above-cited studies<sup>(</sup>
<xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref>
<xref rid="ref10" ref-type="bibr">
</xref>
<sup>,</sup>
<xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>,</sup>
<xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref>
<sup>,</sup>
<xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref>
<sup>)</sup> may stem from the delivery form of strawberry (freeze-dried form
<italic>v</italic>. SCP extract) or cranberry (juice, dried fruit forms or SCP extract), the
experimental design (acute <italic>v</italic>. longer term), the polyphenol dose or the
population studied. In the present study, the SCP were a SCP enriched extract providing 333
mg/d of polyphenols and was devoid of fibres, sugars, minerals and vitamins. On the one
hand, this amount of polyphenols, which corresponds to the quantity supplied by about 120 g
of fresh fruits, is equivalent to approximately one-fourth the level of polyphenols present
in the freeze-dried strawberry powder used by Basu <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<xref rid="ref8" ref-type="bibr">
</xref>
<sup>)</sup> and Moazen <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref50" ref-type="bibr">
<sup>50</sup>
</xref>
<sup>)</sup> (1001&#x02013;2006 mg polyphenols/d) and in the low-energy cranberry juice used in
previous studies<sup>(</sup>
<xref rid="ref10" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>,</sup>
<xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>,</sup>
<xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref>
<sup>)</sup>. On the other hand, the key difference between the SCP extract used in the
present study and these other sources of polyphenols is the lack of fermentable fibres. It
is well recognised that strawberries<sup>(</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>)</sup> and cranberries<sup>(</sup>
<xref rid="ref55" ref-type="bibr">
<sup>55</sup>
</xref>
<sup>)</sup> contain significant amounts of fermentable soluble and insoluble fibres that
may reduce lipids, inflammatory and oxidative markers<sup>(</sup>
<xref rid="ref56" ref-type="bibr">
<sup>56</sup>
</xref>
<sup>)</sup>. Therefore, the lack of dietary fibre in our extract is among the plausible
explanations for the absence of an SCP effect on lipids, inflammatory and oxidative markers
in the current study. Moreover, the present results and those from a study by Hokayem
<italic>et al.</italic>
<sup>(</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup> who used a berry (grape) polyphenol extract, suggest that the various phenol
compounds present in berries may specifically improve insulin sensitivity in humans.</p><p>The participants in this study were insulin resistant and included both sexes and a
relatively broad age range (40&#x02013;70 years). Given the free-living nature of the study, the
results can most likely apply to an overweight adult pre-diabetic population. Despite the
parallel arm design and polyphenol content of the beverage used, the present study did allow
sufficient power to detect statistical differences on the primary endpoint of insulin
sensitivity. However, this study was not sufficiently powered to detect differences on
secondary endpoints, in particular hsCRP, TNF-<italic>&#x003b1;</italic> and oxidised-LDL. Yet, it
would have been interesting to obtain muscle and adipose tissue biopsies to test whether SCP
reduced inflammation in these tissues. Such biopsies may have also allowed us to ascertain
the identity of the molecules involved in cellular insulin signalling. Nonetheless,
considering the robust nature of our randomised, controlled, double-blind study, it is
likely that the consumption of SCP resulted in the improvement in the
hyperinsulinaemic-euglycaemic clamp insulin sensitivity and OGTT parameters. Finally, since
this is a proof-of-concept study, it will be necessary to consider longer-term interventions
in larger populations of subjects to confirm the results and expand upon the potential role
of SCP in preventing or delaying the onset of type 2 diabetes.</p><p>In conclusion, our data indicate that 6-week consumption of 333 mg polyphenols from
strawberries and cranberries may improve insulin sensitivity and prevent an increase in
compensatory insulin secretion without affecting plasma lipids, CRP, pro-inflammatory
cytokines and antioxidant capacity. Controlled dose&#x02013;response trials are needed to ascertain
the lower and upper range of activity of these polyphenols, as well as larger and
longer-term studies.</p></sec></body><back><ack id="ack1"><title>Acknowledgements</title><p>The authors are grateful to Marie-Christine Dub&#x000e9;, Louise Rh&#x000e9;aume, Val&#x000e9;rie-&#x000c8;ve Julien, Marie
Tremblay and Camille Lambert, from the Diabetes Research Unit (Laval University Health
Center of Quebec) who helped in performing hyperinsulinaemic-euglycaemic clamps and Steeve
Larouche and Danielle Aubin, the nurses who performed OGTT (INAF, Laval University). The
authors also thank H&#x000e9;l&#x000e8;ne Cr&#x000e9;peau from Laval University, for help with statistical analysis
and the subjects who participated in this study. Finally, the authors acknowledge
Jean-Paul-Houle Funds, Diab&#x000e8;te Qu&#x000e9;bec and INAF for scholarships. The present study was
supported by the Consortium de recherche et innovations en bioproc&#x000e9;d&#x000e9;s industriels au
Qu&#x000e9;bec, Atrium Innovations Inc. and Nutra Canada. Parts of this study were presented in
abstract form at the 17th Annual Canadian Diabetes Association/Canadian Society of
Endocrinology and Metabolism (CDA/CSEM) Professional Conference &#x00026; Annual Meetings,
Winnipeg, Manitoba, Canada, 22&#x02013;25 October 2014.</p><p>The authors&#x02019; contributions were as follows: S. J. W., Y. D., A. M. and H. J. designed
research. J. M. and H. J. planned the study. M. P. and J. M. conducted research. M. P. and
A. S. M.-L. performed statistical analysis. M. P., S. J. W., Y. D., A. M. and H. J wrote the
paper. S. D. performed polyphenol determinations. H. J. had primary responsibility for the
final content. M. P., A. S. M.-L., S. J. W., Y. D., J. M., G. P., S. D., A. M. and H. J.
contributed to the discussion and data interpretation. All authors have read and approved
the final manuscript. The study funders had no role in the study design or in the
collection, analysis, interpretation of data and decision to publish. The authors have sole
responsibility for the manuscript content.</p><p>None of the authors has any conflicts of interest to declare.</p></ack><sec sec-type="supplementary-material" id="sec4"><title>Supplementary material</title><supplementary-material content-type="local-data" id="S0007114517000393sup001"><p>For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0007114517000393.</p><media xlink:href="S0007114517000393sup001.zip" mimetype="application" mime-subtype="zip" orientation="portrait" id="d35e3903" position="anchor"><caption><p>click here to view supplementary material</p></caption></media></supplementary-material></sec><ref-list id="refs"><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="book">
<collab>International Diabetes Federation</collab> (<year>2013</year>) <source>IDF
Diabetes Atlas</source>, <edition>6th ed</edition> pp.
<fpage>11</fpage>&#x02013;<lpage>12</lpage>. <publisher-loc>Brussels</publisher-loc>:
<publisher-name>International Diabetes Federation</publisher-name>.</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal">
<name><surname>Anderson</surname><given-names>JW</given-names></name>, <name><surname>Kendall</surname><given-names>CW</given-names></name> &#x00026; <name><surname>Jenkins</surname><given-names>DJ</given-names></name> (<year>2003</year>) <article-title>Importance of weight management in type 2
diabetes: review with meta analysis of clinical studies</article-title>. <source>J Am
Coll Nutr</source>
<volume>22</volume>, <fpage>331</fpage>&#x02013;<lpage>339</lpage>.<pub-id pub-id-type="pmid">14559925</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal">
<name><surname>Jeon</surname><given-names>CY</given-names></name>, <name><surname>Lokken</surname><given-names>RP</given-names></name>, <name><surname>Hu</surname><given-names>FB</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Physical activity of
moderate intensity and risk of type 2 diabetes: a systematic review</article-title>.
<source>Diabetes Care</source>
<volume>30</volume>, <fpage>744</fpage>&#x02013;<lpage>752</lpage>.<pub-id pub-id-type="pmid">17327354</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal">
<name><surname>Wellen</surname><given-names>KE</given-names></name> &#x00026; <name><surname>Hotamisligil</surname><given-names>GS</given-names></name> (<year>2005</year>) <article-title>Inflammation, stress, and
diabetes</article-title>. <source>J Clin Invest</source>
<volume>115</volume>, <fpage>1111</fpage>&#x02013;<lpage>1119</lpage>.<pub-id pub-id-type="pmid">15864338</pub-id></mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal">
<name><surname>Mursu</surname><given-names>J</given-names></name>, <name><surname>Virtanen</surname><given-names>JK</given-names></name>, <name><surname>Tuomainen</surname><given-names>TP</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Intake of fruit, berries,
and vegetables and risk of type 2 diabetes in Finnish men: the Kuopio Ischaemic Heart
Disease Risk Factor Study</article-title>. <source>Am J Clin Nutr</source>
<volume>99</volume>, <fpage>328</fpage>&#x02013;<lpage>333</lpage>.<pub-id pub-id-type="pmid">24257723</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal">
<name><surname>Basu</surname><given-names>A</given-names></name>, <name><surname>Fu</surname><given-names>DX</given-names></name>, <name><surname>Wilkinson</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Strawberries decrease
atherosclerotic markers in subjects with metabolic syndrome</article-title>.
<source>Nutr Res</source>
<volume>30</volume>, <fpage>462</fpage>&#x02013;<lpage>469</lpage>.<pub-id pub-id-type="pmid">20797478</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal">
<name><surname>Basu</surname><given-names>A</given-names></name>, <name><surname>Wilkinson</surname><given-names>M</given-names></name>, <name><surname>Penugonda</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Freeze-dried strawberry
powder improves lipid profile and lipid peroxidation in women with metabolic syndrome:
baseline and post intervention effects</article-title>. <source>Nutr J</source>
<volume>8</volume>, <fpage>43</fpage>.<pub-id pub-id-type="pmid">19785767</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal">
<name><surname>Burton-Freeman</surname><given-names>B</given-names></name>, <name><surname>Linares</surname><given-names>A</given-names></name>, <name><surname>Hyson</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Strawberry modulates LDL
oxidation and postprandial lipemia in response to high-fat meal in overweight
hyperlipidemic men and women</article-title>. <source>J Am Coll Nutr</source>
<volume>29</volume>, <fpage>46</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">20595645</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal">
<name><surname>Ruel</surname><given-names>G</given-names></name>, <name><surname>Pomerleau</surname><given-names>S</given-names></name>, <name><surname>Couture</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Favourable impact of
low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in
men</article-title>. <source>Br J Nutr</source>
<volume>96</volume>, <fpage>357</fpage>&#x02013;<lpage>364</lpage>.<pub-id pub-id-type="pmid">16923231</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal">
<name><surname>Basu</surname><given-names>A</given-names></name>, <name><surname>Betts</surname><given-names>NM</given-names></name>, <name><surname>Ortiz</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Low-energy cranberry juice
decreases lipid oxidation and increases plasma antioxidant capacity in women with
metabolic syndrome</article-title>. <source>Nutr Res</source>
<volume>31</volume>, <fpage>190</fpage>&#x02013;<lpage>196</lpage>.<pub-id pub-id-type="pmid">21481712</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal">
<name><surname>Ruel</surname><given-names>G</given-names></name>, <name><surname>Pomerleau</surname><given-names>S</given-names></name>, <name><surname>Couture</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Changes in plasma
antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term
cranberry juice consumption</article-title>. <source>Metabolism</source>
<volume>54</volume>, <fpage>856</fpage>&#x02013;<lpage>861</lpage>.<pub-id pub-id-type="pmid">15988692</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal">
<name><surname>Afrin</surname><given-names>S</given-names></name>, <name><surname>Gasparrini</surname><given-names>M</given-names></name>, <name><surname>Forbes-Hernandez</surname><given-names>TY</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Promising health benefits
of the strawberry: a focus on clinical studies</article-title>. <source>J Agric Food
Chem</source>
<volume>64</volume>, <fpage>4435</fpage>&#x02013;<lpage>4449</lpage>.<pub-id pub-id-type="pmid">27172913</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal">
<name><surname>Giampieri</surname><given-names>F</given-names></name>, <name><surname>Forbes-Hernandez</surname><given-names>TY</given-names></name>, <name><surname>Gasparrini</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Strawberry as a health
promoter: an evidence based review</article-title>. <source>Food Funct</source>
<volume>6</volume>, <fpage>1386</fpage>&#x02013;<lpage>1398</lpage>.<pub-id pub-id-type="pmid">25803191</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal">
<name><surname>Novotny</surname><given-names>JA</given-names></name>, <name><surname>Baer</surname><given-names>DJ</given-names></name>, <name><surname>Khoo</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Cranberry juice
consumption lowers markers of cardiometabolic risk, including blood pressure and
circulating C-reactive protein, triglyceride, and glucose concentrations in
adults</article-title>. <source>J Nutr</source>
<volume>145</volume>, <fpage>1185</fpage>&#x02013;<lpage>1193</lpage>.<pub-id pub-id-type="pmid">25904733</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal">
<name><surname>Szajdek</surname><given-names>A</given-names></name> &#x00026; <name><surname>Borowska</surname><given-names>EJ</given-names></name> (<year>2008</year>) <article-title>Bioactive compounds and health-promoting
properties of berry fruits: a review</article-title>. <source>Plant Foods Hum Nutr</source>
<volume>63</volume>, <fpage>147</fpage>&#x02013;<lpage>156</lpage>.<pub-id pub-id-type="pmid">18931913</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal">
<name><surname>Hanhineva</surname><given-names>K</given-names></name>, <name><surname>T&#x000f6;rr&#x000f6;nen</surname><given-names>R</given-names></name>, <name><surname>Bondia-Pons</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Impact of dietary
polyphenols on carbohydrate metabolism</article-title>. <source>Int J Mol Sci</source>
<volume>11</volume>, <fpage>1365</fpage>&#x02013;<lpage>1402</lpage>.<pub-id pub-id-type="pmid">20480025</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal">
<name><surname>Nizamutdinova</surname><given-names>IT</given-names></name>, <name><surname>Jin</surname><given-names>YC</given-names></name>, <name><surname>Chung</surname><given-names>JI</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>The anti-diabetic effect
of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4
regulation and prevention of insulin resistance and pancreatic
apoptosis</article-title>. <source>Mol Nutr Food Res</source>
<volume>53</volume>, <fpage>1419</fpage>&#x02013;<lpage>1429</lpage>.<pub-id pub-id-type="pmid">19785000</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal">
<name><surname>Denis</surname><given-names>MC</given-names></name>, <name><surname>Desjardins</surname><given-names>Y</given-names></name>, <name><surname>Furtos</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Prevention of oxidative
stress, inflammation and mitochondrial dysfunction in the intestine by different
cranberry phenolic fractions</article-title>. <source>Clin Sci (Lond)</source>
<volume>128</volume>, <fpage>197</fpage>&#x02013;<lpage>212</lpage>.<pub-id pub-id-type="pmid">25069567</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal">
<name><surname>Takikawa</surname><given-names>M</given-names></name>, <name><surname>Inoue</surname><given-names>S</given-names></name>, <name><surname>Horio</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Dietary anthocyanin-rich
bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of
AMP-activated protein kinase in diabetic mice</article-title>. <source>J Nutr</source>
<volume>140</volume>, <fpage>527</fpage>&#x02013;<lpage>533</lpage>.<pub-id pub-id-type="pmid">20089785</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal">
<name><surname>DeFronzo</surname><given-names>RA</given-names></name>, <name><surname>Tobin</surname><given-names>JD</given-names></name> &#x00026; <name><surname>Andres</surname><given-names>R</given-names></name> (<year>1979</year>) <article-title>Glucose clamp technique: a method for
quantifying insulin secretion and resistance</article-title>. <source>Am J Physiol</source>
<volume>237</volume>, <fpage>E214</fpage>&#x02013;<lpage>E223</lpage>.<pub-id pub-id-type="pmid">382871</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal">
<name><surname>Antuna-Puente</surname><given-names>B</given-names></name>, <name><surname>Disse</surname><given-names>E</given-names></name>, <name><surname>Rabasa-Lhoret</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>How can we measure insulin
sensitivity/resistance?</article-title>
<source>Diabetes Metab</source>
<volume>37</volume>, <fpage>179</fpage>&#x02013;<lpage>188</lpage>.<pub-id pub-id-type="pmid">21435930</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal">
<name><surname>Stull</surname><given-names>AJ</given-names></name>, <name><surname>Cash</surname><given-names>KC</given-names></name>, <name><surname>Johnson</surname><given-names>WD</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Bioactives in blueberries
improve insulin sensitivity in obese, insulin-resistant men and women</article-title>.
<source>J Nutr</source>
<volume>140</volume>, <fpage>1764</fpage>&#x02013;<lpage>1768</lpage>.<pub-id pub-id-type="pmid">20724487</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal">
<name><surname>Hokayem</surname><given-names>M</given-names></name>, <name><surname>Blond</surname><given-names>E</given-names></name>, <name><surname>Vidal</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Grape polyphenols prevent
fructose-induced oxidative stress and insulin resistance in first-degree relatives of
type 2 diabetic patients</article-title>. <source>Diabetes Care</source>
<volume>36</volume>, <fpage>1454</fpage>&#x02013;<lpage>1461</lpage>.<pub-id pub-id-type="pmid">23275372</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal">
<name><surname>Dudonn&#x000e9;</surname><given-names>S</given-names></name>, <name><surname>Dub&#x000e9;</surname><given-names>P</given-names></name>, <name><surname>Pilon</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Modulation of
strawberry/cranberry phenolic compounds glucuronidation by co-supplementation with
onion: characterization of phenolic metabolites in rat plasma using an optimized
<italic>&#x003bc;</italic>SPE-UHPLC-MS/MS method</article-title>. <source>J Agric Food Chem</source>
<volume>62</volume>, <fpage>3244</fpage>&#x02013;<lpage>3256</lpage>.</mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal">
<collab>Expert Committee on the Diagnosis and Classification of Diabetes Mellitus</collab>
(<year>2003</year>) <article-title>Follow-up report on the diagnosis of diabetes
mellitus</article-title>. <source>Diabetes Care</source>
<volume>26</volume>, <fpage>3160</fpage>&#x02013;<lpage>3167</lpage>.<pub-id pub-id-type="pmid">14578255</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal">
<name><surname>Labonte</surname><given-names>ME</given-names></name>, <name><surname>Cyr</surname><given-names>A</given-names></name>, <name><surname>Baril-Gravel</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Validity and
reproducibility of a web-based, self-administered food frequency
questionnaire</article-title>. <source>Eur J Clin Nutr</source>
<volume>66</volume>, <fpage>166</fpage>&#x02013;<lpage>173</lpage>.<pub-id pub-id-type="pmid">21934698</pub-id></mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal">
<name><surname>Piche</surname><given-names>ME</given-names></name>, <name><surname>Weisnagel</surname><given-names>SJ</given-names></name>, <name><surname>Corneau</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Contribution of abdominal
visceral obesity and insulin resistance to the cardiovascular risk profile of
postmenopausal women</article-title>. <source>Diabetes</source>
<volume>54</volume>, <fpage>770</fpage>&#x02013;<lpage>777</lpage>.<pub-id pub-id-type="pmid">15734855</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal">
<name><surname>Richterich</surname><given-names>R</given-names></name> &#x00026; <name><surname>Dauwalder</surname><given-names>H</given-names></name> (<year>1971</year>) <article-title>Determination of plasma glucose by hexokinase-
glucose-6-phosphate dehydrogenase method</article-title>. <source>Schweiz Med Wochenschr</source>
<volume>101</volume>, <fpage>615</fpage>&#x02013;<lpage>618</lpage>.<pub-id pub-id-type="pmid">5576952</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal">
<name><surname>Desbuquois</surname><given-names>B</given-names></name> &#x00026; <name><surname>Aurbach</surname><given-names>GD</given-names></name> (<year>1971</year>) <article-title>Use of polyethylene glycol to separate free and
antibody-bound peptide hormones in radioimmunoassays</article-title>. <source>J Clin
Endocrinol Metab</source>
<volume>33</volume>, <fpage>732</fpage>&#x02013;<lpage>738</lpage>.<pub-id pub-id-type="pmid">5166455</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal">
<name><surname>Couillard</surname><given-names>C</given-names></name>, <name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name>, <name><surname>Lamarche</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Effects of endurance
exercise training on plasma HDL cholesterol levels depend on levels of triglycerides:
evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE)
Family Study</article-title>. <source>Arterioscler Thromb Vasc Biol</source>
<volume>21</volume>, <fpage>1226</fpage>&#x02013;<lpage>1232</lpage>.<pub-id pub-id-type="pmid">11451756</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal">
<name><surname>Pich&#x000e9;</surname><given-names>ME</given-names></name>, <name><surname>Lemieux</surname><given-names>S</given-names></name>, <name><surname>Weisnagel</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Relation of
high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and
fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride
levels in healthy postmenopausal women</article-title>. <source>Am J Cardiol</source>
<volume>96</volume>, <fpage>92</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">15979442</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal">
<name><surname>Rubi&#x000f3;</surname><given-names>L</given-names></name>, <name><surname>Serra</surname><given-names>A</given-names></name>, <name><surname>Chen</surname><given-names>CY</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Effect of the co-occurring
components from olive oil and thyme extracts on the antioxidant status and its
bioavailability in an acute ingestion in rats</article-title>. <source>Food Funct</source>
<volume>5</volume>, <fpage>740</fpage>&#x02013;<lpage>747</lpage>.<pub-id pub-id-type="pmid">24554091</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal">
<name><surname>Ouellet</surname><given-names>V</given-names></name>, <name><surname>Marois</surname><given-names>J</given-names></name>, <name><surname>Weisnagel</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Dietary cod protein
improves insulin sensitivity in insulin-resistant men and women: a randomized controlled
trial</article-title>. <source>Diabetes Care</source>
<volume>30</volume>, <fpage>2816</fpage>&#x02013;<lpage>2821</lpage>.<pub-id pub-id-type="pmid">17682120</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal">
<name><surname>Balion</surname><given-names>CM</given-names></name>, <name><surname>Raina</surname><given-names>PS</given-names></name>, <name><surname>Gerstein</surname><given-names>HC</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Reproducibility of
impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a
systematic review</article-title>. <source>Clin Chem Lab Med</source>
<volume>45</volume>, <fpage>1180</fpage>&#x02013;<lpage>1185</lpage>.<pub-id pub-id-type="pmid">17635074</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal">
<name><surname>Borai</surname><given-names>A</given-names></name>, <name><surname>Livingstone</surname><given-names>C</given-names></name>, <name><surname>Kaddam</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Selection of the
appropriate method for the assessment of insulin resistance</article-title>. <source>BMC
Med Res Methodol</source>
<volume>11</volume>, <fpage>158</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">22112229</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal">
<name><surname>Edirisinghe</surname><given-names>I</given-names></name>, <name><surname>Banaszewski</surname><given-names>K</given-names></name>, <name><surname>Cappozzo</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Strawberry anthocyanin and
its association with postprandial inflammation and insulin</article-title>. <source>Br J
Nutr</source>
<volume>106</volume>, <fpage>913</fpage>&#x02013;<lpage>922</lpage>.<pub-id pub-id-type="pmid">21736853</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal">
<name><surname>Park</surname><given-names>E</given-names></name>, <name><surname>Edirisinghe</surname><given-names>I</given-names></name>, <name><surname>Choy</surname><given-names>YY</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Effects of grape seed
extract beverage on blood pressure and metabolic indices in individuals with
pre-hypertension: a randomised, double-blinded, two-arm parallel, placebo-controlled
trial</article-title>. <source>Br J Nutr</source>
<volume>115</volume>, <fpage>226</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">26568249</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal">
<name><surname>Addison</surname><given-names>S</given-names></name>, <name><surname>Stas</surname><given-names>S</given-names></name>, <name><surname>Hayden</surname><given-names>MR</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Insulin resistance and
blood pressure</article-title>. <source>Curr Hypertens Rep</source>
<volume>10</volume>, <fpage>319</fpage>&#x02013;<lpage>325</lpage>.<pub-id pub-id-type="pmid">18625163</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal">
<name><surname>Kim</surname><given-names>JA</given-names></name>, <name><surname>Montagnani</surname><given-names>M</given-names></name>, <name><surname>Koh</surname><given-names>KK</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Reciprocal relationships
between insulin resistance and endothelial dysfunction: molecular and pathophysiological
mechanisms</article-title>. <source>Circulation</source>
<volume>113</volume>, <fpage>1888</fpage>&#x02013;<lpage>1904</lpage>.<pub-id pub-id-type="pmid">16618833</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal">
<name><surname>Rodriguez-Mateos</surname><given-names>A</given-names></name>, <name><surname>Rendeiro</surname><given-names>C</given-names></name>, <name><surname>Bergillos-Meca</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Intake and time dependence
of blueberry flavonoid-induced improvements in vascular function: a randomized,
controlled, double-blind, crossover intervention study with mechanistic insights into
biological activity</article-title>. <source>Am J Clin Nutr</source>
<volume>98</volume>, <fpage>1179</fpage>&#x02013;<lpage>1191</lpage>.<pub-id pub-id-type="pmid">24004888</pub-id></mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal">
<name><surname>Kahn</surname><given-names>SE</given-names></name>, <name><surname>Prigeon</surname><given-names>RL</given-names></name>, <name><surname>McCulloch</surname><given-names>DK</given-names></name>, <etal>et al</etal> (<year>1993</year>) <article-title>Quantification of the
relationship between insulin sensitivity and beta-cell function in human subjects.
Evidence for a hyperbolic function</article-title>. <source>Diabetes</source>
<volume>42</volume>, <fpage>1663</fpage>&#x02013;<lpage>1672</lpage>.<pub-id pub-id-type="pmid">8405710</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal">
<name><surname>Pratley</surname><given-names>RE</given-names></name> &#x00026; <name><surname>Weyer</surname><given-names>C</given-names></name> (<year>2002</year>) <article-title>Progression from IGT to type 2 diabetes
mellitus: the central role of impaired early insulin secretion</article-title>.
<source>Curr Diab Rep</source>
<volume>2</volume>, <fpage>242</fpage>&#x02013;<lpage>248</lpage>.<pub-id pub-id-type="pmid">12643180</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal">
<name><surname>Anh&#x000ea;</surname><given-names>FF</given-names></name>, <name><surname>Roy</surname><given-names>D</given-names></name>, <name><surname>Pilon</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>A polyphenol-rich
cranberry extract protects from diet-induced obesity, insulin resistance and intestinal
inflammation in association with increased <italic>Akkermansia</italic> spp. population
in the gut microbiota of mice</article-title>. <source>Gut</source>
<volume>64</volume>, <fpage>872</fpage>&#x02013;<lpage>883</lpage>.<pub-id pub-id-type="pmid">25080446</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal">
<name><surname>Feliciano</surname><given-names>RP</given-names></name>, <name><surname>Boeres</surname><given-names>A</given-names></name>, <name><surname>Massacessi</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Identification and
quantification of novel cranberry-derived plasma and urinary
(poly)phenols</article-title>. <source>Arch Biochem Biophys</source>
<volume>599</volume>, <fpage>31</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">26836705</pub-id></mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal">
<name><surname>Scheepens</surname><given-names>A</given-names></name>, <name><surname>Tan</surname><given-names>K</given-names></name> &#x00026; <name><surname>Paxton</surname><given-names>JW</given-names></name> (<year>2010</year>) <article-title>Improving the oral bioavailability of
beneficial polyphenols through designed synergies</article-title>. <source>Genes Nutr</source>
<volume>5</volume>, <fpage>75</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">19841960</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal">
<name><surname>Yoon</surname><given-names>SA</given-names></name>, <name><surname>Kang</surname><given-names>SI</given-names></name>, <name><surname>Shin</surname><given-names>HS</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>
<italic>p</italic>-Coumaric acid modulates glucose and lipid metabolism via
AMP-activated protein kinase in L6 skeletal muscle cells</article-title>.
<source>Biochem Biophys Res Commun</source>
<volume>432</volume>, <fpage>553</fpage>&#x02013;<lpage>557</lpage>.<pub-id pub-id-type="pmid">23485470</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal">
<name><surname>Prabhakar</surname><given-names>PK</given-names></name> &#x00026; <name><surname>Doble</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Interaction of cinnamic acid derivatives with
commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1
adipocytes</article-title>. <source>J Agric Food Chem</source>
<volume>59</volume>, <fpage>9835</fpage>&#x02013;<lpage>9844</lpage>.<pub-id pub-id-type="pmid">21870829</pub-id></mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal">
<name><surname>Cardona</surname><given-names>F</given-names></name>, <name><surname>Andr&#x000e9;s-Lacueva</surname><given-names>C</given-names></name>, <name><surname>Tulipani</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Benefits of polyphenols on
gut microbiota and implications in human health</article-title>. <source>J Nutr Biochem</source>
<volume>24</volume>, <fpage>1415</fpage>&#x02013;<lpage>1422</lpage>.<pub-id pub-id-type="pmid">23849454</pub-id></mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>IT</given-names></name>, <name><surname>Chan</surname><given-names>YC</given-names></name>, <name><surname>Lin</surname><given-names>CW</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Effect of cranberry
extracts on lipid profiles in subjects with type 2 diabetes</article-title>.
<source>Diabet Med</source>
<volume>25</volume>, <fpage>1473</fpage>&#x02013;<lpage>1477</lpage>.<pub-id pub-id-type="pmid">19046248</pub-id></mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal">
<name><surname>Moazen</surname><given-names>S</given-names></name>, <name><surname>Amani</surname><given-names>R</given-names></name>, <name><surname>Homayouni Rad</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Effects of freeze-dried
strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with
type 2 diabetes: a randomized double-blind controlled trial</article-title>. <source>Ann
Nutr Metab</source>
<volume>63</volume>, <fpage>256</fpage>&#x02013;<lpage>264</lpage>.<pub-id pub-id-type="pmid">24334868</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal">
<name><surname>Ruel</surname><given-names>G</given-names></name>, <name><surname>Pomerleau</surname><given-names>S</given-names></name> &#x00026; <name><surname>Couture</surname><given-names>P</given-names></name> (<year>2008</year>) <article-title>Low-calorie cranberry juice supplementation
reduces plasma oxidized LDL and cell adhesion molecule concentrations in
men</article-title>. <source>Br J Nutr</source>
<volume>99</volume>, <fpage>352</fpage>&#x02013;<lpage>359</lpage>.<pub-id pub-id-type="pmid">17761017</pub-id></mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal">
<name><surname>Zunino</surname><given-names>SJ</given-names></name>, <name><surname>Parelman</surname><given-names>MA</given-names></name>, <name><surname>Freytag</surname><given-names>TL</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Effects of dietary
strawberry powder on blood lipids and inflammatory markers in obese human
subjects</article-title>. <source>Br J Nutr</source>
<volume>108</volume>, <fpage>900</fpage>&#x02013;<lpage>909</lpage>.<pub-id pub-id-type="pmid">22068016</pub-id></mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="journal">
<name><surname>Ellis</surname><given-names>CL</given-names></name>, <name><surname>Edirisinghe</surname><given-names>I</given-names></name>, <name><surname>Kappagoda</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Attenuation of
meal-induced inflammatory and thrombotic responses in overweight men and women after
6-week daily strawberry (<italic>Fragaria</italic>) intake &#x02013; a randomized
placebo-controlled trial</article-title>. <source>J Atheroscler Thromb</source>
<volume>18</volume>, <fpage>318</fpage>&#x02013;<lpage>327</lpage>.<pub-id pub-id-type="pmid">21242652</pub-id></mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal">
<name><surname>Quir&#x000f3;s-Sauceda</surname><given-names>AE</given-names></name>, <name><surname>Palafox-Carlos</surname><given-names>H</given-names></name>, <name><surname>S&#x000e1;yago-Ayerdi</surname><given-names>SG</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Dietary fiber and phenolic
compounds as functional ingredients: interaction and possible effect after
ingestion</article-title>. <source>Food Funct</source>
<volume>5</volume>, <fpage>1063</fpage>&#x02013;1010.<pub-id pub-id-type="pmid">24740575</pub-id></mixed-citation></ref><ref id="ref55"><label>55.</label><mixed-citation publication-type="journal">
<name><surname>Hotchkiss</surname><given-names>AT</given-names><suffix>Jr</suffix></name>, <name><surname>Nu&#x000f1;ez</surname><given-names>A</given-names></name>, <name><surname>Strahan</surname><given-names>GD</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Cranberry xyloglucan
structure and inhibition of <italic>Escherichia coli</italic> adhesion to epithelial
cells</article-title>. <source>J Agric Food Chem</source>
<volume>63</volume>, <fpage>5622</fpage>&#x02013;<lpage>5633</lpage>.<pub-id pub-id-type="pmid">25973733</pub-id></mixed-citation></ref><ref id="ref56"><label>56.</label><mixed-citation publication-type="journal">
<name><surname>Erkkil&#x000e4;</surname><given-names>AT</given-names></name> &#x00026; <name><surname>Lichtenstein</surname><given-names>AH</given-names></name> (<year>2006</year>) <article-title>Fiber and cardiovascular disease risk: how
strong is the evidence?</article-title>
<source>J Cardiovasc Nurs</source>
<volume>21</volume>, <fpage>3</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16407729</pub-id></mixed-citation></ref></ref-list></back></article>